Arginine/Omega-3 Fatty Acids/Nucleotides Nutritional Supplement
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Arginine/Omega-3 Fatty Acids/Nucleotides Nutritional Supplement, covering 2025-02-13 to 2025-02-13. Get the full timeline:
Most recent: Clinical Trial Update: Arginine/Omega-3 Fatty Acids/Nucleotides Nutritional Supplement in Treating Patients With Stage III or Stage IV Head and Neck Cancer Undergoing Chemotherapy and Radiation Therapy [Phase 2]